Market Research Logo

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022

About Post-Traumatic Stress Disorder (PTSD) Therapeutics

PTSD) therapeutics include drugs that are used in the treatment of PTSD.

Technavio’s analysts forecast the global post-traumatic stress disorder (PTSD) therapeutics market to grow at a CAGR of 1.26% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global post-traumatic stress disorder (PTSD) therapeutics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of post-traumatic stress disorder (PTSD) therapeutics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly and Company
  • H. Lundbeck
Market driver
  • Increasing initiatives by public and private organizations
  • For a full, detailed list, view our report
Market challenge
  • Unmet need for existing therapies
  • For a full, detailed list, view our report
Market trend
  • Emerging therapies for PTSD treatment
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global post-traumatic stress disorder (PTSD) therapeutics market: GlaxoSmithKline, Pfizer , Eli Lilly and Company, H. Lundbeck

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Emerging therapies for PTSD treatment Many pharmacologic agents are being tested as novel pharmacotherapies for PTSD. Some of the promising agents gaining increasing R&D focus include MDMA, ketamine, and glucocorticoids. MAPS is a non-profit research and educational organization that is funding the clinical trials of MDMA as a tool to assist psychotherapy for the treatment of PTSD. In its Phase II trial with 107 participants, it found that 61% of the participants are no longer qualified for PTSD after three sessions of MDMA-assisted psychotherapy, two months after the treatment. At the 12-month follow-up, 68% participants no longer had PTSD. All participants had chronic, treatment-resistant PTSD, and had suffered from PTSD for an average of 17.8 years.”

According to the report, one of the major drivers for this market is Increasing initiatives by public and private organizations. Several public and private organizations are taking initiatives to raise awareness about PTSD and improve access to its treatment. For instance, to bring greater awareness about PTSD, the US Senate has designated June 27th as the national PTSD awareness day.

Further, the report states that one of the major factors hindering the growth of this market is Unmet need for existing therapies. The PTSD medications currently approved by the FDA for the treatment of PTSD (paroxetine and sertraline) do not improve the full range of its symptoms. They show little evidence of treatment effect in men and lack clinical evidence of efficacy in people whose traumatic event was combat-related and carry suicidality warnings. Furthermore, the approved SSRIs and SNRIs have been associated with mild to moderate side effects such as upset stomach, sweating, headache, dizziness, and sexual side effects such as decreased desire to have sex or difficulty in having an orgasm.

https://www.technavio.com/industries/central-nervous-system

Companies Mentioned

GlaxoSmithKline, Pfizer , Eli Lilly and Company, H. Lundbeck

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global CNS disorders therapeutics market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline landscape
    • Table Major pipeline products
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global PTSD therapeutics market Market size and forecast 2017-2022 ($ mn)
      • Table Global PTSD therapeutics market Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by product
    • Segmentation by product
      • Table Global PTSD therapeutics market Market share 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • Antidepressants
      • Table Antidepressants market Market size and forecast 2017-2022 ($ mn)
      • Table Antidepressants market Year-over-year growth 2018-2022 (%)
    • Anxiolytics
      • Table Anxiolytics market Market size and forecast 2017-2022 ($ mn)
      • Table Anxiolytics market Year-over-year growth 2018-2022 (%)
    • Other PTSD therapeutics
      • Table Other PTSD therapeutics Market size and forecast 2017-2022 ($ mn)
      • Table Other PTSD therapeutics Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global PTSD therapeutics market Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • PTSD therapeutics market in Americas
      • Table PTSD therapeutics market in Americas Market size and forecast 2017-2022 ($ mn)
      • Table PTSD therapeutics market in Americas Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • PTSD therapeutics market in EMEA
      • Table PTSD therapeutics market in EMEA Market size and forecast 2017-2022 ($ mn)
      • Table PTSD therapeutics market in EMEA Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • PTSD therapeutics market in APAC
      • Table PTSD therapeutics market in APAC Market size and forecast 2017-2022 ($ mn)
      • Table PTSD therapeutics market in APAC Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Emerging therapies for PTSD treatment
    • Increasing focus on clinical research by pharmaceutical companies and institutions
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • GlaxoSmithKline
      • Table GlaxoSmithKline Overview
      • Table GlaxoSmithKline Business segments
      • Table GlaxoSmithKline Organizational developments
      • Table GlaxoSmithKline Geographic focus
      • Table GlaxoSmithKline Segment focus
      • Table GlaxoSmithKline Key offerings
      • Table GlaxoSmithKline Key customers
    • Pfizer
      • Table Pfizer Overview
      • Table Pfizer Business segments
      • Table Pfizer Organizational developments
      • Table Pfizer Geographic focus
      • Table Pfizer Segment focus
      • Table Pfizer Key offerings
      • Table Pfizer Key customers
    • Eli Lilly and Company
      • Table Eli Lilly and Company Overview
      • Table Eli Lilly and Company Business segments
      • Table Eli Lilly and Company Organizational developments
      • Table Eli Lilly and Company Geographic focus
      • Table Eli Lilly and Company Segment focus
      • Table Eli Lilly and Company Key offerings
      • Table Eli Lilly and Company Key customers
    • H. Lundbeck
      • Table H. Lundbeck Overview
      • Table H. Lundbeck Business segments
      • Table H. Lundbeck Organizational developments
      • Table H. Lundbeck Geographic focus
      • Table H. Lundbeck Segment focus
      • Table H. Lundbeck Key offerings
      • Table H. Lundbeck Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report